Gennova's mRNA-based vaccine to be delayed

​​​Gennova had last month submitted interim data on India's first indigenously developed mRNA Covid vaccine to the drug regulator. The Central Drug Standard Control Organisation (CDSCO) has sent some queries to the company on the data, the people said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/I0BRtCV
via IFTTT